Terlipressin for hepatorenal syndrome

Lise Lotte Gluud; Kurt Christensen; Erik Christensen; Aleksander Krag

doi:10.1002/14651858.CD005162.pub3

Terlipressin for hepatorenal syndrome

Lise Lotte Gluud, Kurt Christensen, Erik Christensen, Aleksander Krag

91 Citations (Scopus)

Abstract

Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concerning mortality is equivocal.

Original language	English
Journal	Cochrane Database of Systematic Reviews
Volume	9
Pages (from-to)	CD005162
ISSN	1469-493X
DOIs	https://doi.org/10.1002/14651858.CD005162.pub3
Publication status	Published - 2012

Keywords

Albumins
Hepatorenal Syndrome
Humans
Lypressin
Randomized Controlled Trials as Topic
Vasoconstrictor Agents

Access to Document

10.1002/14651858.CD005162.pub3

Cite this

@article{854e8a6f2ffc4bf2a5b5a25a58624ce9,

title = "Terlipressin for hepatorenal syndrome",

abstract = "Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concerning mortality is equivocal.",

keywords = "Albumins, Hepatorenal Syndrome, Humans, Lypressin, Randomized Controlled Trials as Topic, Vasoconstrictor Agents",

author = "Gluud, \{Lise Lotte\} and Kurt Christensen and Erik Christensen and Aleksander Krag",

year = "2012",

doi = "10.1002/14651858.CD005162.pub3",

language = "English",

volume = "9",

pages = "CD005162",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Terlipressin for hepatorenal syndrome

AU - Gluud, Lise Lotte

AU - Christensen, Kurt

AU - Christensen, Erik

AU - Krag, Aleksander

PY - 2012

Y1 - 2012

N2 - Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concerning mortality is equivocal.

AB - Clinical trials suggest that terlipressin improves renal function in hepatorenal syndrome, but the evidence concerning mortality is equivocal.

KW - Albumins

KW - Hepatorenal Syndrome

KW - Humans

KW - Lypressin

KW - Randomized Controlled Trials as Topic

KW - Vasoconstrictor Agents

UR - https://www.scopus.com/pages/publications/84873021017

U2 - 10.1002/14651858.CD005162.pub3

DO - 10.1002/14651858.CD005162.pub3

M3 - Journal article

C2 - 22972083

SN - 1469-493X

VL - 9

SP - CD005162

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Terlipressin for hepatorenal syndrome

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this